Survivorship Post-Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: A Systematic Review.

ABSTRACT:

Introduction

Retroperitoneal lymph node dissection (RPLND) may be considered after chemotherapy or as primary treatment in patients with metastatic testicular cancer. We aimed to perform a systematic review to analyze outcomes in survivors across the domains of sexual, physical, and psychological function. It is the first systematic review of outcomes of survivorship following RPLND.

Methods

A systematic review was performed as per PRISMA guidelines. Outcomes were extracted from studies meeting the inclusion criteria and were analyzed.

Results

In total, there were 11 studies included with 1086 patients. Of these, 80.5% had stage 1 disease and 63.1% had nerve-sparing surgery. Clavien-Dindo 1-2 post-operative complications were reported in 14.1% of cases and Clavien-Din

SUBMITTER: Calpin GG 

PROVIDER: S-EPMC12410126 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature